Quantcast
Last updated on April 18, 2014 at 17:24 EDT

DrugRisk Alerts of Judicial Update as NuvaRing Lawsuits Show Increase

July 3, 2013

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

New York, NY (PRWEB) July 03, 2013

The birth control safety advocates at DrugRisk.com are announcing updated news for women using the contraceptive NuvaRing. A judge recently ruled patients alleging blood clot injuries can seek punitive damages as the number of lawsuits has increased in recent months*.

DrugRisk was created to improve the safety and awareness of patients using popular prescription drugs by providing the latest safety alerts, recalls, studies and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

So far, nearly 1,100 patients have filed a NuvaRing lawsuit alleging blood clots in a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. Hundreds more have been filed in a New Jersey multi-district court (In re: NuvaRing Litigation (BER-L-3081-09, Superior Court of New Jersey, Bergen County)).

The resource center has learned that the latest court records show the number of claims has increased from 1,097 on March 5th to 1,163 as of May 15th, an increase of over 6%***. The first trial for these lawsuits has been scheduled to start in October****.

Now, DrugRisk has added information that Judge Brian R. Martinotti, of the New Jersey court, ordered that patients can seek punitive damages against the maker of the device for alleged blood clot injuries*. However, DrugRisk cautions this is not an indication of the success or failure of any particular case.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judge Brian R. Martinotti, 5/3/13; In re: NuvaRing Litigation (BER-L-3081-09, Superior Court of New Jersey, Bergen County); judiciary.state.nj.us/mass-tort/nuvaring/orders_decisions.htm

**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840

***Judicial Panel on Multidistrict Litigation, 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf

****U.S. District Judge Rodney Sippel, 3/8/13; cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/nuvaring-settlement/update-lawsuit-info/prweb10897142.htm


Source: prweb